NOI to Sole Source to 10X Genomics
NOI-OD-26-009308 · HEALTH AND HUMAN SERVICES, DEPARTMENT OF
A IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING solicitation, performed in Bethesda, MD, with responses due 2026-09-23. AwardCast estimates what this specific solicitation will close for, before you bid.
What's being bought
The purpose of this requirement is for the acquisition of reagents and consumables required for the Early Detection of Lung Diseases (EDLI) project. These reagents are specifically designed and exclusively compatible with the 10X Genomics Chromium platform, a proprietary system that enables high-res
Comparable recent awards in IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING
| Winner | Award value | Offers | Date |
|---|---|---|---|
| REMEL INC. | $64K | n/a | 2026-07-02 |
| CEPHEID | $306K | n/a | 2026-07-01 |
| BECTON, DICKINSON AND COMPANY | $21K | 1 | 2026-07-01 |
| ABBOTT LABORATORIES INC. | $102K | 1 | 2026-07-01 |
| ROCHE DIAGNOSTICS CORPORATION | $615K | 1 | 2026-07-01 |
Questions
What is solicitation NOI-OD-26-009308?
NOI to Sole Source to 10X Genomics, issued by HEALTH AND HUMAN SERVICES, DEPARTMENT OF, under NAICS 325413 (IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING), performed in Bethesda, MD. Responses are due 2026-09-23.
What do similar contracts close for?
Comparable closed awards in this category ran from $21K to $615K, across 5 awards shown above. Those are historical results, not a forecast for this solicitation.
Is NOI-OD-26-009308 set aside?
NONE. Check the notice on SAM.gov for the eligibility language that governs.
Explore the market
Forecast Report — what a specific solicitation will close for: the predicted price range, the competition to expect, and comparable awards already closed. Before you price your bid.
Every forecast is scored against the real award once it becomes public. See the track record.
Closed awards from public federal data, not the forecast. One email, no account.
Or get the forecast for this solicitation — $49, one report.